Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Correction: Susceptibility to Transmitting HIV in Patients Initiating Antiretroviral Therapy in Rural District Hospitals in Cameroon (Stratall ANRS 12110/ESTHER Trial).

Autor: Gilbert Ndziessi, Julien Cohen, Charles Kouanfack, Fabienne Marcellin, Maria Patrizia Carrieri, Gabrièle Laborde-Balen, Camélia Protopopescu, Avelin Fobang Aghokeng, Jean-Paul Moatti, Bruno Spire, Eric Delaporte, Christian Laurent, Sylvie Boyer, M. Biwolé-Sida, C. Kouanfack, S. Koulla-Shiro, A. Bourgeois, E. Delaporte, C. Laurent, M. Peeters, G. Laborde-Balen, M. Dontsop, S. Kazé, J-M. Mben, A. Aghokeng, M.G. Edoul, E. Mpoudi-Ngolé, M. Tongo, S. Boyer, M.P. Carrieri, F. Marcellin, J-P. Moatti, B. Spire, C. Abé, S-C. Abega, C-R. Bonono, H. Mimcheu, S. Ngo Yebga, C. Paul Bile, S. Abada, T. Abanda, J. Baga, P. Bilobi Fouda, P. Etong Mve, G. Fetse Tama, H. Kemo, A. Ongodo, V. Tadewa, HD. Voundi, A. Ambani, M. Atangana, J-C. Biaback, M. Kennedy, H. Kibedou, F. Kounga, M. Maguip Abanda, E. Mamang, A. Mikone, S. Tang, E. Tchuangue, S. Tchuenko, D. Yakan, J. Assandje, S. Ebana, D. Ebo’o, D. Etoundi, G. Ngama, P. Mbarga Ango, J. Mbezele, G. Mbong, C. Moung, N. Ekotto, G. Nguemba Balla, G. Ottou, M. Tigougmo, R. Beyala, B. Ebene, C. Effemba, F. Eyebe, M-M. Hadjaratou, T. Mbarga, M. Metou, M. Ndam, B. Ngoa, EB. Ngock, N. Obam, A. M. Abomo, G. Angoula, E. Ekassi, Essama, J.J. Lentchou, I. Mvilongo, J. Ngapou, F. Ntokombo, V. Ondoua, R. Palawo, S. Sebe, E. Sinou, D. Wankam, I. Zobo, B. Akono, A. L. Ambani, L. Bilock, R. Bilo’o, J. Boombhi, F.X. Fouda, M. Guitonga, R. Mad’aa, D.R. Metou’ou, S. Mgbih, A. Noah, M. Tadena, Ntcham, G. Ambassa Elime, A.A. Bonongnaba, E. Foaleng, R.M. Heles, R. Messina, O. Nana Ndankou, S.A. Ngono, D. Ngono Menounga, S.S. Sil, L. Tchouamou, B. Zambou, R. Abomo, J. Ambomo, C. Beyomo, P. Eloundou, C. Ewole, J. Fokom, M. Mvoto, M. Ngadena, R. Nyolo, C. Onana, A. Oyie, P. Antyimi, S. Bella Mbatonga, M. Bikomo, Y. Molo Bodo, S. Ndi Ntang, P. Ndoudoumou, L. Ndzomo, S.O. Ngolo, M. Nkengue, Nkoa, Y. Tchinda

Publikováno v: PLoS ONE, Vol 8, Iss 7 (2013)

Externí odkaz: https://doaj.org/article/46b5bc0cc49749b394fef67ee65de858

Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa

Autor: S, Boyer, M L, Nishimwe, L, Sagaon-Teyssier, L, March, S, Koulla-Shiro, M-Q, Bousmah, R, Toby, M P, Mpoudi-Etame, N F, Ngom Gueye, A, Sawadogo, C, Kouanfack, L, Ciaffi, B, Spire, E, Delaporte, F, Simon

Publikováno v: PharmacoEconomics-Open
PharmacoEconomics-Open, 2020, 4 (1), pp.45-60. ⟨10.1007/s41669-019-0157-9⟩
PharmacoEconomics-open / Pharmacoecon Open
PharmacoEconomics-open / Pharmacoecon Open, [Cham, Switzerland] : Springer International Publishing AG, [2017]-, 2020, 4 (1), pp.45-60. ⟨10.1007/s41669-019-0157-9⟩
PharmacoEconomics Open
PharmacoEconomics-Open, [Cham, Switzerland] : Springer International Publishing AG, [2017]-, 2020, 4 (1), pp.45-60. ⟨10.1007/s41669-019-0157-9⟩

Background While dolutegravir has been added by WHO as a preferred second-line option for the treatment of HIV infection, boosted protease inhibitor (bPI)-based regimens are still needed as alternative second-line options. Identifying optimal bPI-bas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::52f9b975777637d8129b87d343f6bafe
https://hal.science/hal-02510696/document

Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial

Autor: Laura Ciaffi, Sinata Koulla-Shiro, Adrien Bruno Sawadogo, Cheik Tidiane Ndour, Sabrina Eymard-Duvernay, Pretty Rosereine Mbouyap, Liliane Ayangma, Jacques Zoungrana, Ndeye Fatou Ngom Gueye, Mohamadou Diallo, Suzanne Izard, Guillaume Bado, Coumba Toure Kane, Avelin Fobang Aghokeng, Martine Peeters, Pierre Marie Girard, Vincent Le Moing, Jacques Reynes, Eric Delaporte, J Reynes, E Delaporte, S Koulla-Shiro, CT Ndour, AB Sawadogo, M Seidy, V Le Moing, A Calmy, L Ciaffi, NF Ngom Gueye, PM Girard, S Eholie, JB Guiard-Schmid, ML Chaix, C Kouanfack, I Tita, B Bazin, P Garcia, S Izard, S Eymard-Duvernay, M Peeters, L Serrano, A Cournil, PR Mbouyap, R Toby, N Manga, L Ayangma, M Mpoudi, Ngole J Zoungrana, M Diallo, AF Aghokeng, E Guichet, O Bell, H Abessolo Abessolo, MR Djoubgang, G Manirakiza, G Lamarre, T Mbarga, S Epanda, A Bikie, T Nke, N Massaha, E Nke, D Bikobo, J Olinga, O Elat, A Diop, B Diouf, N Bara, MB Koita Fall, C Toure Kane, FB Seck, S Ba, P Njantou, A Ndyaye, P Fao, R Traore, Y Sanou, G Bado, M Coulibaly, E Some, J Some, A Kambou, A Tapsoba, D Sombie, S Sanou, B Traore, P Flandre, C Michon, J Drabo, F Simon

Publikováno v: Lancet HIV
Lancet HIV, 2017, 4 (9), pp.e384--e392. ⟨10.1016/S2352-3018(17)30069-3⟩
Lancet HIV, Elsevier, 2017, 4 (9), pp.e384--e392. ⟨10.1016/S2352-3018(17)30069-3⟩

Despite satisfactory efficacy of WHO-recommended second-line antiretroviral treatment for patients with HIV in low-income countries, the need for simplified, low-cost, and less-toxic maintenance strategies remains high. We compared boosted protease i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e134a5a3ec01e9f053cb6a49d0a556f0
https://hal.science/hal-01761365

Tenofovir plasma concentrations related to estimated glomerular filtration rate changes in first-line regimens in African HIV-infected patients: ANRS 12115 DAYANA substudy

Autor: A. Benalycherif, Maryvonne Maynart, Mamadou-Baila Diallo, Sinata Koulla-Shiro, A. Ouattara, Charles Kouanfack, F. Ngom Gueye, Mireille Mpoudi Ngolle, S. Koulla-Shiro, Halimatou Diop, P.S. Sow, Aïda Benalycherif, Roland Landman, B. Ndiaye, R. Landman, Moussa Diallo, Ndeye Fatou Ngom Gueye, O. Elad, V. Le Moing, Maguy Ngolle, A. Sock, Claudine Ntsama Essomba, Papa-Salif Sow, Charlotte Charpentier, Sabrina Eymard-Duvernay, M B Koita Fall, E. Simen, P. M. Girard, C. Charpentier, C. Touré Kane, Gilles Peytavin, B. Ymele, Minh Patrick Lê, Avelin F. Aghokeng, S. Eymard-Duvernay, G. Peytavin, Sylvie Legac, Eric Delaporte, A. Thiam, Vincent Le Moing, Pierre-Marie Girard, E. Delaporte

Publikováno v: Journal of Antimicrobial Chemotherapy
Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2015, 70 (5), pp.1517-1521. ⟨10.1093/jac/dku532⟩

Objectives An open-label randomized trial (DAYANA) was conducted in sub-Saharan settings to evaluate four different regimens containing tenofovir disoproxil fumarate as first-line treatment for HIV infection. The objectives of the present substudy we

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e5299978eda4794aa4c7165b78b8621
https://pubmed.ncbi.nlm.nih.gov/25583749